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OBJECTIVE: Rheumatoid arthritis (RA) is a costly and crippling autoimmune disease that can lead to the
development of depression, contributing to suboptimal clinical outcomes. However, no longitudinal studies
have identified an association between rheumatoid arthritis and subsequent depression. This study aimed to
investigate the incidence and risk factors of depression among RA patients in Taiwan.
METHODS: Using Taiwan’s National Health Insurance Research Database, we identified 3,698 newly diagnosed
RA patients aged 18 years or older, together with 7,396 subjects without RA matched by sex, age and index
date, between 2000 and 2004. The incidence of depression and the risk factors among RA cases were evaluated
using Cox proportional-hazard regression.
RESULTS: The incidence of depression was 1.74-fold greater in the RA cohort than in the non-RA cohort (11.80
versus 6.89 per 1,000 person-years; p,0.01). Multivariate analysis showed that RA subjects who were female,
were older, or had comorbidities such as stroke, chronic kidney disease, or cancer had a significantly greater risk
of depression compared with those without these conditions.
CONCLUSION: This population-based cohort study showed a strong relationship between RA and a subsequent
risk of depression. The findings could be beneficial to healthcare providers for identifying individuals with a
higher predisposition for depression, thereby possibly facilitating the provision of an appropriate rehabilitation
intervention after RA onset to support the patient’s adaptation.
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& INTRODUCTION
Rheumatoid arthritis (RA) is a debilitating disease
characterized by chronic symmetric polyarthritis involving
peripheral small joints that affects 0.3-1.0% of the popula-
tion worldwide (1). Most individuals first experience RA
between 30 and 50 years of age (2). Approximately 20-30%
of these individuals are unable to work within 3 years
following diagnosis, which places a tremendous burden on
the patients, their families and the healthcare system (3).
Accordingly, a report from the American College of
Rheumatology Subcommittee showed that RA is responsi-
ble for 250,000 hospitalizations and 9 million physician
visits each year (4). Additionally, Birnbaum et al. (5)
reported that the annual direct medical costs for RA in the
US were $19.3 billion, with the total societal costs (the sum
of direct costs and indirect costs) estimated to exceed $39
billion.
RA not only results in enormous economic losses but also
presents a significant public health problem. Recently, RA
has been proven to be a major risk factor for many chronic
conditions such as cancer, cardiovascular disease, kidney
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dysfunction and respiratory disease (2,6). A review by
Sokka et al. reported that RA patients had a 50-60% greater
risk of death from all causes compared with individuals
without RA (7). Due to the irreversible nature of RA and the
poor clinical responses of RA patients, psychiatric disorders,
especially depression, are commonly found among RA
patients. Indeed, the prevalence of depression among RA
patients is estimated to range from 14.8 to 38.8% (8) and
patients with RA are five times more likely to experience
depression than the general population (9). RA patients
suffering from concomitant depression had a 7.2% ($12,225
vs. $11,404) increase in medical costs (10) and their
likelihood of mortality compared with patients with RA
only was more than doubled (11). Therefore, it is important
to clarify the factors that may lead to depression and to then
incorporate appropriate treatment for these factors into the
routine care of RA patients.
Although some studies on depression among RA subjects
have been conducted, most have been performed in
Western countries (9,12-14). In particular, Chinese patients
often consider depression to be a taboo subject and are
highly reluctant to openly discuss this problem with others
(15). Previous studies of Chinese RA patients have often
focused on disease outcomes during pregnancy (16),
epidemiological reports (17), or the subsequent risk of
cancer following RA onset (18). Consequently, only limited
data are available on psychological issues, especially
depression, among Asian patients with RA. Of the few
studies conducted that have examined factors related to
depression among Chinese RA patients, there are major
weaknesses such as the absence of a control group, a small
sample size, or a cross-sectional design (19,20). To fill this
gap in the literature, we conducted a follow-up study to
assess the association between RA and the subsequent risk
of depression, together with risk factors, in Asian patients
using claims data obtained from the National Health
Insurance (NHI) of Taiwan. Although this is a preliminary
study of depression in RA patients, its findings should assist
healthcare providers in identifying potential cases of
depression and provide an empirical rationale for initiating
more timely and efficient interventions for RA patients.
& METHODS
Data sources
All analytic data were retrieved from the Longitudinal
Health Insurance Database (LHID), which is maintained by
the Bureau of National Health Insurance (BNHI) and
provided to scientists in Taiwan for research purposes. In
1995, Taiwan launched a single-payer NHI Program to
remove the financial barriers to medical care for all legal
residents. At the end of 2010, .99% of Taiwan’s population
had enrolled in this program (21). The LHID is a subset of
the NHI database and contains comprehensive utilization
and enrollment information for one million randomly
selected NHI beneficiaries, representing 5% of all enrollees
in Taiwan in 2000. Because a multistage, stratified,
systematic sampling method was used for this study, there
were no statistically significant differences regarding sex or
age between the sample group and the total number of
enrollees (21). This study was approved by the local
institutional review board and ethics committee of
Buddhist Dalin Tzu Chi Hospital, Taiwan (No. B101030014).
Study subjects
Diagnoses in the patient insurance claims data were
coded according to the International Classification of
Disease, 9th Revision, Clinical Modification (ICD-9-CM).
The LHID records were used to identify adult patients with
RA aged $18 years and newly diagnosed between 2000 and
2004. Patients who were identified with an ICD code of
714.0 comprised the RA cohort. To eliminate errors resulting
from misclassification, we selected RA subjects who had at
least 2 RA diagnoses in the ambulatory service or those who
were admitted to the hospital with a primary RA diagnosis
during the 5-year period. This approach was based on the
method adopted by former researchers using administrative
databases (22,23). The index date was defined as the date of
the first RA diagnosis.
Based on gender, age and index date, each RA patient was
matched with 2 control-group patients from a reference
population not registered with an RA diagnosis. Each
subject in the control group was assigned the same index
date as the corresponding RA patient. After excluding
subjects with a history of depression at baseline, a total of
3,698 RA patients and 7,396 non-RA control subjects were
included in the data analysis. Patients were considered to
have a history of depression if they had $2 outpatient visits
or at least one inpatient claim of depression (ICD-9-CM
codes of 296.2, 296.3, 300.4 or 311) since 1996, when the
computerized claims data from the LHID were available,
until the date of cohort entry. All subjects were followed up
to the end of 2011 to measure the incidence of depression
based on the above-mentioned criteria: at least two
ambulatory visits or one hospitalization with the diagnosis
of depression. The date of their first medical visit due to
depression was established as the starting point for their
time at risk with depression. Follow-up person-years (PYs)
were calculated as the time interval from the entry date to
the earliest occurrence of one of the following: a diagnosis of
depression, the date of withdrawal from insurance, or
December 31, 2011.
Demographic variables and disease characteristics
The demographic variables used in this study included
age, gender, income for estimating insurance payment and
urbanization level of the subject’s residential area. The
monthly incomes were divided into 3 levels: #New Taiwan
Dollar (NTD) 17,880, NTD 17,881–NTD 43,900, and $NTD
43,901. Urbanization levels were divided into 3 strata based
on population density: urban (levels 1–2), suburban (levels
3–4) and rural (levels 5–7) areas. Level 1 refers to the ‘‘most
urbanized’’ and level 7 refers to the ‘‘least urbanized’’
communities (24). Disease characteristics included the
presence of a chronic disease such as hypertension (ICD-9-
CM 401-405), stroke (ICD-9-CM 430-438), diabetes (ICD-9-
CM 250), heart disease (ICD-9-CM 410-429), chronic kidney
disease (ICD-9-CM 585) and cancer (ICD-9-CM 140-208).
Additionally, medication usage was stratified into two
groups according to whether the subjects had received
DMARDs or biological agents for more than three months
after the index date.
Statistical analysis
The x2 test was used to examine differences in demo-
graphic variables and disease characteristics between the
RA and control cohorts. The depression incidence rate for
the 2 cohorts was presented as the number of cases per 1,000
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PYs. A Cox proportional hazards regression analysis was
applied to compute the hazard ratio (HR) and 95%
confidence interval (CI) of depression for RA compared
with the control cohort. The multivariate Cox proportional
hazards model was used to identify risk factors that might
predict depression and their adjusted hazard ratio (aHR)
within the RA cohort. All analyses were performed using
SAS version 9.3 (SAS Institute Inc., Cary, NC, USA) and
p,0.05 was considered statistically significant.
& RESULTS
Baseline characteristics and depression incidence
between the two cohorts
The distributions of demographic variables and disease
characteristics for the RA and control cohorts are shown in
Table 1. RA patients were more likely to reside in a rural
area (p,0.01), take medications (p,0.01) and be diagnosed
with comorbidities such as stroke and diabetes (p,0.05 for
both comorbidities).
Among the study sample of 11,094 patients, a total of 905
first episodes of depression occurred - 413 among the RA
patients and 492 among the control subjects - during the
follow-up of 34,992.62 and 71,449.94 PYs, respectively. The
incidence of depression in the RA cohort was greater than
that in the control group (11.80 vs. 6.89 per 1,000 PYs), with
an aHR of 1.74 (95% CI 1.48, 1.95; Table 2).
Risk factors of depression in RA subjects
A multivariate Cox proportional-hazard regression ana-
lysis was used to estimate the aHR of depression among RA
patients based on demographic data and disease character-
istics (Table 3). The data showed that age and gender are
significantly related to the risk of depression in RA patients.
In addition, the risk of depression was 19% greater for
subjects aged $70 years compared with those aged ,18
years (95% CI 1.02-1.38). Compared with male gender,
female gender was related to an aHR of 1.77 for depression
(95% CI 1.52-2.07). Additionally, the presence of a comor-
bidity increased the risk of depression, with patients with
cancer having the highest risk (aHR: 2.47, 95% CI 1.46-4.20),
followed by those with chronic kidney disease (aHR: 2.32,
95% CI 1.10-4.88) and stroke (aHR: 1.84, 95% CI 1.14-2.96).
& DISCUSSION
This is the first study to utilize a national administrative
database to address the relationship between RA and
subsequent depression in an Asian population. Due to the
relatively low RA incidence, a large sample size is required
to obtain sufficient statistical power for a proper analysis.
Table 1 - Demographic data and comorbidity comparison of the study subjects.
Variables Non-RA RA p
N = 7,396 (%) N = 3,698 (%)
Age, (years) 0.99
,50 2653 (35.9) 1326 (35.9)
50–69 3151 (42.6) 1579 (42.7)
$70 1592 (21.5) 793 (21.4)
Mean (SD) 55.76 (15.24) 55.75 (15.24) 0.98
Gender
Female 4864 (65.8) 2432 (65.8)
Male 2532 (34.2) 1266 (34.2)
Monthly income 0.24
Low 2142 (29.0) 1075 (29.1)
Median 4626 (62.6) 2344 (63.4)
High 626 (8.5) 279 (7.5)
Level of urbanization ,0.01
Urban 4226 (57.2) 2055 (55.6)
Suburban 1150 (15.6) 529 (14.3)
Rural 2018 (27.3) 1114 (30.1)
Medication usage ,0.01
Yes 14 (0.2) 414 (11.2)
No 7382 (99.8) 3284 (88.8)
Comorbidity
Hypertension 594 (8.0) 331 (9.0) 0.10
Stroke 62 (0.8) 55 (1.5) ,0.01
Diabetes 267 (3.6) 173 (4.7) 0.01
Heart disease 218 (2.9) 125 (3.4) 0.22
Chronic kidney disease 29 (0.4) 12 (0.3) 0.58
Cancer 32 (0.8) 16 (0.6) 0.12
Table 2 - Crude and adjusted hazard ratios of depression for RA patients compared with non-RA controls.
Patient group Event PY Incidence Crude HR (95% CI) aHR* (95% CI)
Controls 492 71449.94 6.89 1 1
RA patients 413 34992.62 11.80 1.72 (1.51–1.96) 1.74 (1.48-1.95)
Incidence rate is per 1,000 person-years.
*The model was adjusted for age, gender, urbanization level, monthly income, medication usage and comorbidities.
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Previous studies have nearly always been conducted using
hospitalized patients, which may limit the number of
patients observed and lead to possible selection bias.
Therefore, the present population-based data using age-
and sex-matched control groups allowed for a better
validation of the results than the data obtained in previous
studies. Additionally, our cohort study design using nation-
wide claims-based data allowed us to examine the temporal
association between RA and depression risk.
Our study suggests that RA patients have a 74% increased
risk of depression compared with similarly aged control
subjects in a general population, which is in agreement with
the results of prior studies conducted in Western popula-
tions (9,12,13,25). Possible explanations for our results
include the following. First, RA is a chronic, unremitting
disease with no known cure. Severe RA can cause
progressive functional impairments that affect community
involvement, work, family life and social and recreational
activities. These effects may lower the patient’s self-esteem
and self-efficacy thereby inducing a higher risk for depres-
sion (26). Second, the debilitating and continuous physical
RA symptoms may trigger ‘‘learned helplessness’’ cogni-
tions, such that one’s inability to successfully cope with
physical deterioration and life-threatening situations results
in increased levels of uncertainty, unpredictability and
ultimately, emotional distress and depression (27). Third,
the symptoms manifested by RA are directly associated
with experiencing chronic pain and the latter has been
linked to increased levels of depression (28). Fourth, tumor
necrosis factor-a (TNF-a) and interleukin 1 (IL-1) are the
pivotal cytokines involved in RA (29) and these pro-
inflammatory agents have been considered as pathogenic
factors associated with the mechanism of developing
depression (26,30). In fact, a meta-analysis of 22 studies
indicated that inflammatory cytokines may regulate adult
neurogenesis to induce hippocampal neurogenesis atrophy,
which has been implicated as a key contributing factor in
the pathophysiology of depression and is a target of novel
treatment strategies (31).
The incidence of depression among RA patients in our
study was lower than that in a previous report (11.80/1,000
PYs vs. 55.0/1,000 PYs) (25). This variation may be due to
methodological discrepancies such as variations in sample
sizes and differences in the assessment tools employed. In
this previous report (25), the psychiatric diagnosis of
depression was made based on a self-administered ques-
tionnaire that assessed symptoms only, which may have
reduced the accuracy of the data due to recall bias. In
addition, due to their conservative Asian culture, Chinese
subjects tend to stigmatize psychiatric illness and seldom
discuss or openly seek regular psychiatric treatment for this
issue (15). Notably, some studies have reported that ,20%
of RA patients were treated and referred to appropriate
psychiatric services after the onset of the disease (19,32).
Therefore, it is imperative to implement a standard care
process that identifies those groups with a higher predis-
position for developing depression in an effort to provide
early referral to psychiatric treatment.
With respect to the correlates of depression, the findings
from the multivariate analysis indicated that age is
positively correlated with the risk of depression. One
possibility is that older RA patients have other age-
associated functional declines that might aggravate their
psychological distress. However, this result is inconsistent
with findings reported in 3 other studies (13,14,33). Such
conflicting findings may be due to differences among the
participants and designs of the various studies. For
example, the participants in the latter studies were
Westerners, who may have been more open to discussing
psychiatric disorders. This openness could possibly have
lessened or moderated the effect of age on the risk of
depression. Furthermore, most prior studies were con-
ducted using a cross-sectional design that made it difficult
to reach clear conclusions. The retrospective cohort-con-
trolled design employed in our study allowed us to make
more reliable conclusions concerning the relationship
between age and depression among RA patients.
Our study revealed that females are 1.78-fold more likely
to suffer from depression than males, which was consistent
with the findings of previous reports (12,30). A possible
reason for this finding is that women have been shown to be
more health-conscious than men and more likely to pursue
treatment at the earliest sign of medical irregularity (34),
thus increasing the probability of detecting depression. Our
results, however, are inconsistent with those of other studies
showing only a marginally increased rate of depression in
female RA patients (20,32). The contradictory results in
these former studies may be due to the low statistical power
Table 3 - Multivariate analysis of factors related to the
risk of depression among RA patients.
Variable Crude HR (95% CI) Adjusted HR* (95% CI)
Age, (years)
,50 1 1
50–69 1.09 (0.91-1.31) 1.13 (0.92-1.37)
$70 1.20 (1.04-1.39) 1.19 (1.02-1.38)
Gender
Male 1 1
Female 1.78 (1.52-2.08) 1.77 (1.52-2.07)
Monthly income
Low 1.16 (0.89-1.52) 1.01 (0.86-1.17)
Median 1.08 (0.84-1.39) 1.07 (0.81-1.41)
High 1 1
Level of urbanization
Urban 1.14 (0.97-1.33) 1.17 (0.98-1.36)
Suburban 1.06 (0.86-1.31) 1.10 (0.86-1.33)
Rural 1
Medication usage
Yes 1.30 (0.97-1.79) 1.27 (0.94-1.69)
No 1 1
Comorbidity
Stroke
No 1 1
Yes 1.65 (1.04-2.64) 1.84 (1.14-2.96)
Hypertension
No 1 1
Yes 1.07 (0.85-1.34) 1.02 (0.77-1.25)
Diabetes
No 1 1
Yes 1.09 (0.79-1.51) 1.03 (0.74-1.36)
Heart disease
No 1 1
Yes 1.17 (0.83-1.65) 1.14 (0.80-1.63)
Chronic kidney disease
No 1 1
Yes 2.19 (1.04-4.61) 2.32 (1.10-4.88)
Cancer
No 1 1
Yes 2.29 (1.35-3.88) 2.47 (1.46-4.20)
*Adjusted for all variables in the model.
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resulting from small sample sizes, with only 113 and 200
participants recruited per study.
Regarding the effect of comorbidity on the risk of
depression, the present study showed that RA patients
with certain comorbidities, including chronic kidney dis-
ease, stroke or cancer, have a significantly greater risk of
depression. RA patients with hypertension, diabetes melli-
tus and heart disease showed a tendency to develop
depression, but the association failed to reach statistical
significance. Despite the lack of comparative studies on the
effects of comorbidities, our findings are, nevertheless, in
agreement with arguments made in the literature (30)
suggesting that comorbidities among RA patients may be
associated with a predisposition for developing depression.
We speculate that the comorbidities accompanying RA
might negatively affect the patients’ perceptions of their
health status or reduce their ability to withstand therapy-
induced side effects and other complications stemming
from their condition, thus leading to a higher risk of
depression. Furthermore, a recent review article reported
that depressive mood may be related to the types of drugs a
patient receives such as oncologic medications, corticoster-
oids or biological agents (35). Therefore, clinicians are
encouraged to carefully appraise the effects of a medication
prior to using it to treat RA patients with depression. This
approach could be beneficial in reducing the risk for
depression following an RA diagnosis.
The following limitations merit consideration when
considering the findings of this study. First, we did not
account for other confounding factors such as the use of
tobacco and alcohol, physical activity, body mass index,
social networks, religious beliefs and educational level
because they were unavailable in the LHID. Accordingly,
caution must be exercised when interpreting this study’s
findings. Nonetheless, a meta-analysis of the depression risk
estimate in RA found that RA per se could predict a
predisposition toward depression through the activation of
pro-inflammatory cytokines (29). Nonetheless, future stu-
dies using more specific covariates are recommended to
assess whether the present findings can be replicated among
other demographically and geographically diverse groups.
In addition, the relationship of depression prognostic
outcomes among RA patients should be considered.
Second, inaccurate diagnoses may have occurred. To
minimize this error, we selected subjects with RA or
depression only after they were recorded to have at least 2
outpatient visits reporting consistent diagnoses or one
inpatient admission. Furthermore, the Taiwan NHI ran-
domly samples claims from hospitals, interviews patients
and reviews medical charts to verify the accuracy of medical
records. Third, as data regarding RA severity were not
available in this claims database, failure to adjust for this
factor might have biased the results. However, the multi-
variate analysis applied considered the impact of several
comorbidities with physical impairments, including hyper-
tension, stroke, DM, heart disease, CKD and cancer.
Furthermore, we conducted a sensitivity analysis limited
to RA subjects without comorbidities and found that these
patients with RA still had a significantly higher incidence
rate and aHR of depression (11.51 vs. 6.49 per 1000 PYs;
aHR: 1.78). Thus, the impact of disease severity is unlikely
to compromise the results of this study. Despite these
methodological concerns, this population-based, retrospec-
tive cohort study provides useful information on the
relationship between RA and the subsequent risk of
depression among Chinese patients.
In conclusion, this study demonstrates that the RA
patients evaluated were 1.74 times more likely to be
diagnosed with depression than the general population
after adjusting for several potentially influential covariates.
The factors leading to an increased risk of depression
among RA patients included being female and older, as well
as having certain comorbidities such as stroke, chronic
kidney disease and cancer. The data from this population-
based study allow healthcare providers to further under-
stand the demographic and disease characteristics that may
provoke depression among RA patients. The need to
routinely observe patients for signs of depression and to
institute culturally appropriate interventions should be
emphasized.
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